Release date : March 7, 2008
RFA (pdf file)
CSU Infectious Disease SuperCluster
Request for Applications: Infectious Disease Research Proposals
Application receipt date: April 15, 2008; 5:00 P.M.
IDSC MISSION & GOALSThe overall mission and goals of the CSU Infectious Disease SuperCluster (IDSC) are to
- Enhance the overall infectious disease (ID) research, training, and service capacity at CSU and to promote research discoveries, policy development, and capacity to address ID issues in the state, nation, and the world.
- Accelerate development and application of ID products and best practices to detect, prevent and treat human, animal and plant IDs of global importance.
- Partner with industry, government, foundations, and other entities to move discoveries to usable products and best practices into effective policies to combat IDs.
The IDSC will also integrate CSU ID capacity and programs and increase national and international recognition of CSU as a world leader in ID research, product development and control.
PURPOSE OF THE INFECTIOUS DISEASE RESEARCH PROPOSALS
This RFA is for ID SC Research proposals to promote research discovery, to increase ID SC capacity at CSU, and to foster collaborations among CSU investigators. The overall goals are to develop knowledge and products to address the global challenge of IDs.
ID SC research proposals are requested to develop novel vaccines, therapeutics and diagnostics and other potential products to combat infectious diseases of humans, animals, and plants. There are numerous candidate products on campus that would be greatly strengthened for moving into patent applications, licensing, etc., by a few additional experiments, etc. Proposals for those experiments are strongly encouraged. Special consideration will be given this year to translational research proposals which create intellectual property, demonstrate clinical utility and will increase product development opportunities. Innovative, multidisciplinary proposals, which will bridge departments and colleges, are also encouraged (eg, basic and clinical research laboratories, between microbiology or infectious disease laboratories and investigators in other basic disciplines (i.e. engineering, chemistry, agriculture, etc) that will bridge disciplines to develop new ID products. Discussing your proposal with pertinent ID Cluster Leader(s) prior to writing is strongly encouraged. The contact information for each Cluster Leader is provided below in the table. .
WHO CAN APPLY
Submission of proposals in response to the RFA is restricted to members of CSU faculty and collaborators. A CSU faculty member must be the PI. .
SUBMITTING A PROPOSAL
Each year, a call for proposals will be issued, for ID SC research proposals for the ensuing year. This year, research proposals will be due April 15, 2008 at 5:00 p.m. and must follow the instructions provided below. There is a strict limit of 5 pages on the research plan, which includes specific aims, background/significance and rationale, preliminary studies and research design . If there are human investigations or animal experiments proposed, regulatory approvals may be submitted just in time. To facilitate submission, use the proposal template provided. The completed proposal must be submitted electronically per the instructions to the idsc_proposals@mail.colostate.edu.
ID SC RESEARCH PROPOSAL FORMAT
Use the ID SC 2008
Research Proposal Template
Use Arial 11pt font. Sections A-D limited to 5 pages.
Cover page
Abstract:
if funded, the abstract will be posted on the IDSC webstie. Please indicate if
abstract contains proprietary information that must be removed prior to posting.
Budget
Curriculum vitae – NIH Biosketch (2 pages)
Resources and Environment
Research Plan
- Specific Aims
- Background and Significance
- Preliminary Studies/Evidence of multidisciplinary
- Research Design and Methods
- Human Subjects Research – if applicable
- Vertebrate Animals – if applicable
- Literature Cited
- Letters of Support (e.g., Consultants)
- Appendices
Include Proposed Milestones
Also include plan for securing additional funding/support
REVIEW CRITERIA AND SCHEDULE
An ad hoc study section will review the research proposals to determine which applications will be funded. The reviews will be completed and funding initiated by July 1, 2008. Investigators will be notified and accounts established expeditiously in the respective departments. Applications will be reviewed for technical and programmatic merit and potential for product development by the study section.
The criteria for selection used by the MOC will include the following areas:
- Scientific merit - Scientific merit - Clear specific aims with well-referenced body of text; innovation or originality of proposed work; technical feasibility; potential problems addressed; defined milestones; potential for continued/outside funding
- ID product and intellectual property development potential
- Responsive to overall ID SC mission, strategic plan, needs, and opportunities*
- Responsive to the pertinent ID cluster(s) mission (s)
- Evidence of multidisciplinary activities or potential, value added by the collaboration, etc.
- Principal Investigator (s) demonstrated expertise and productivity
*Information on IDSC mission and goals is available on the website program plan. and through the ID Cluster Leaders (see below).
FUNDS AVAILABLE
We anticipate funding 3 to 4 research proposals per year, depending upon funds available. The typical budget for research projects will be $30,000 to $50,000 and will be for one year. Some projects may be funded for a second year, but this will only be in exceptional cases. Renewal proposals will compete for funding for the second year.
WHERE TO SEND INQUIRIES
Direct questions about scientific/research issues to:
Barry Beaty, PhD
Director,
Infectious Disease SuperCluster
Colorado State University
Microbiology, Immunology, and Pathology
Campus Delivery 1690
Fort Collins , CO 80523-1690
Phone: (970)491-2988
bbeaty@colostate.edu
Cluster Leader Contact Information
Cluster Title |
Cluster Leader |
Email address |
Phone |
Ecology of Diseases |
Mike Antolin |
1911 |
|
Therapeutic Agents for Bacterial Pathogens |
Patrick Brennan |
6700 |
|
Detection, Diagnosis and Delivery |
David Dandy |
7437 |
|
Decision Support Systems and Bioinformatics |
Tom Holtzer |
5261 |
|
Prion Diseases |
Ed Hoover |
7587 |
|
Plant Diseases |
Jan Leach |
2924 |
|
Entrepreneurship and Translational Research |
Henry Nowak |
5673 |
|
Virology/Vector Biology |
Ken Olson |
8604 |
|
Epidemiology of IDs |
Mo Salman |
7950 |
|
Food safety |
John Sofos |
7703 |
|
Behavior and Outreach |
Irene Vernon |
2642 |
|
Behavior and Outreach |
Garrett O'Keefe |
3703 |
|
Infectious Diseases Developmental Therapeutics |
Robert Williams |
6747 |
